School of Medicine
Showing 321-340 of 613 Results
-
Paul Goldschmidt
Affiliate, School of Medicine - MDRP'S - Biodesign Program
BioBachelor of Science - Hamburg University of Applied Sciences
Class Tutor - Experimental Physics
Software Engineer / Student Researcher - Stanford Biodesign Digital Health
Founder, CEO @ Dotreflection GmbH - Startup for large-scale medical communication platforms
Member - Permafrost Young Researchers Network (PYRN)
Member - German Physical Society
Scholar, Spokesperson - German Academic Scholarship Foundation (Studienstiftung des Deutschen Volkes) -
Mary Kane Goldstein
Professor of Health Policy, Emerita
Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities
-
Andrea Goldstein-Piekarski
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.
As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.
This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health. -
Deana L. Golini
Coach, SOM Career Center
BioB.S. in Communications, Boston University
M.Ed in Education Administration, Providence College
M.A.E in Art Education, University of Massachusetts Dartmouth -
Ola Golovinsky
Medical Education Team Manager, Psychiatry and Behavioral Sciences
Current Role at StanfordMedical Education Team Manager, Department of Psychiatry & Behavioral Science
-
Eric Matthew Gomez
Administrative Associate 3, Surgery - Vascular Surgery
Current Role at StanfordAdministrative Assistant III in the Department of Vascular Surgery
-
Sandra Natalie Gomez
Postdoctoral Scholar, Psychiatry
BioDr. Sandra N. Gomez is a proud Chicana psychologist. She earned her B.A. in Psychology from Cornell College and her M.Ed. in Counseling Psychology from the University of Missouri–Columbia. She earned her doctorate in Counseling Psychology (Spanish bilingual concentration) from Columbia University, and completed her APA-accredited internship at the University of Miami’s Counseling Center. Currently, she is a postdoctoral clinical psychology fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University, where her clinical and research work bridges her interests in identity development, acculturation, and community healing. At Stanford, she works with high-performance athletes, Latine communities, and families and couples, work that allows her to integrate her commitment to culturally responsive evidence-based practices with her scholarly focus on acculturation, ethnic identity, and the educational and career trajectories of individuals. Rooted in social justice and collective healing, Dr. Gomez also explores the healing potential of movement as a way to deepen connection to self and community. Dr. Gomez is a former APA Interdisciplinary Minority Fellow and Kellogg Legacy Doctoral Mentoring Scholar. She currently serves on the Leadership Council of the National Latinx Psychological Association as the Current Student Representative and is a student reviewer for the Journal of Latinx Psychology.
-
Juan Sebastián Gómez-Cañón
Postdoctoral Scholar, Psychiatry
BioJuan S. Gómez-Cañón is a researcher, engineer and musician from Colombia. He holds a Ph.D. in Information and Communication Technologies from the Universitat Pompeu Fabra (Barcelona, Spain). During his Ph.D., Juan researched human-centered and trustworthy machine learning methods to predict the emotions in music. His research focuses on deep learning, human-centered ML, personalization, dataset curation, and digital signal processing. Juan also holds a M.Sc. in Media Technology (Technische Universität Ilmenau, Germany), a B.Sc. in Electronics Engineering and a B.A. in Music (Universidad de los Andes, Colombia).
-
Natalia Gomez-Ospina
Assistant Professor of Pediatrics (Genetics)
Current Research and Scholarly InterestsDr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.
1) Lysosomal storage diseases:
Her research program is on developing better therapies for a large class of neurodegenerative diseases in children known as lysosomal storage disorders. Her current focus is on developing genome editing of hematopoietic stem cells as a therapeutic approach for these diseases beginning with Mucopolysaccharidosis type 1 and Gaucher disease. She established a genetic approach where therapeutic proteins can be targeted to a single well-characterized place in the genome known as a safe harbor. This approach constitutes a flexible, “one size fits all” approach that is independent of specific genes and mutations. This strategy, in which the hematopoietic system is commandeered to express and deliver therapeutic proteins to the brain can potentially change the current approaches to treating childhood neurodegenerative diseases and pave the way for alternative therapies for adult neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease
2) Point of care ammonia testing
She also works in collaboration with other researchers at Stanford to develop point-of-care testing for serum ammonia levels. Such device will greatly improve the quality of life of children and families with metabolic disorders with hyperammonemia.
3) Gene discovery
Dr Gomez-Ospina lead a multi-institutional collaboration resulting in the discovery of a novel genetic cause of neonatal and infantile cholestatic liver disease. She collaborated in the description of two novel neurologic syndromes caused by mutations in DYRK1 and CHD4.
For more information go to our website:
https://www.gomezospina.com/
